Sign in

Lost your password?
(close)

Adimmune Corporation, Taiwan

Last updated: 13.02.2014

adimmune-logo.jpgFounded in 22nd December 1965, Adimmune Corporation principally engages in R&D, manufacture and sale of vaccines and medicines. Production base is in Tanzi, Taichun. The important well-known product is H1N1 vaccine. IPO issued in Forth January 2010. Our main product is the influenza vaccine. The main product of this company, influenza vaccine, is provided to public in Taiwan by Sanofi-Aventis, Novartis and Glaxo Smith Kline (GSK). Major raw materials are the liquid, syringes, and mice.

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here